Silent Brain Scars Predict Cognitive Decline in Early Multiple Sclerosis
A longitudinal study of early relapsing–remitting multiple sclerosis finds that paramagnetic rim lesions and enlarged choroid plexus volume at diagnosis ...
A longitudinal study of early relapsing–remitting multiple sclerosis finds that paramagnetic rim lesions and enlarged choroid plexus volume at diagnosis ...
A genetic variant linked to faster multiple sclerosis progression is associated with subtly poorer reaction time, fluid intelligence and prospective ...
A large post hoc analysis of the DAYBREAK trial found that only 3.3 percent of patients relapsed after stopping ozanimod, ...
A retrospective real-world study from Milan's San Raffaele institute compares ocrelizumab and ofatumumab as successor therapies for multiple sclerosis patients ...
A Swedish study of 2,117 people with multiple sclerosis found that obesity at diagnosis accelerates long-term disability progression almost exclusively ...
A two-year real-world study found that ofatumumab sustained B-cell depletion in multiple sclerosis patients while producing significant increases in broad ...
A five-year prospective study of people after a first demyelinating event found that age modifies the link between cognitive impairment ...
A new quantitative framework reveals that IgA antibody targeting organizes the gut microbiome and fragments detectably in early multiple sclerosis.
A five-year analysis of early multiple sclerosis patients shows that a single baseline blood neurofilament measurement predicts disease progression only ...
A large Italian registry study finds no significant differences among four first-line multiple sclerosis therapies in protecting against relapse-independent disability ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine